These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 21959954)
1. Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways. Yao M; Zhang W; Zhang Q; Xing L; Xu A; Liu Q; Cui B Lung; 2011 Dec; 189(6):453-60. PubMed ID: 21959954 [TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways. Zhang B; Tao F; Zhang H Mol Med Rep; 2018 Apr; 17(4):4899-4908. PubMed ID: 29393472 [TBL] [Abstract][Full Text] [Related]
3. Nickel-induced VEGF expression via regulation of Akt, ERK1/2, NFκB, and AMPK pathways in H460 cells. Wang JC; Chen SY; Wang M; Ko JL; Wu CL; Chen CC; Lin HW; Chang YY Environ Toxicol; 2019 May; 34(5):652-658. PubMed ID: 30724446 [TBL] [Abstract][Full Text] [Related]
4. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related]
5. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways. Wan J; Wu W J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341 [TBL] [Abstract][Full Text] [Related]
6. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway. Woo JK; Choi Y; Oh SH; Jeong JH; Choi DH; Seo HS; Kim CW Oncogene; 2012 Apr; 31(17):2187-98. PubMed ID: 21927028 [TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer. Yu W; Chen L; Yang YQ; Falck JR; Guo AM; Li Y; Yang J Cancer Chemother Pharmacol; 2011 Sep; 68(3):619-29. PubMed ID: 21120482 [TBL] [Abstract][Full Text] [Related]
9. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC). Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823 [TBL] [Abstract][Full Text] [Related]
11. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling. Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor B coordinates metastasis of non-small cell lung cancer. Liu G; Xu S; Jiao F; Ren T; Li Q Tumour Biol; 2015 Mar; 36(3):2185-91. PubMed ID: 25424698 [TBL] [Abstract][Full Text] [Related]
13. PVT1 Promotes Angiogenesis by Regulating miR-29c/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway in Non-Small-Cell Lung Cancer (NSCLC). Mao Z; Xu B; He L; Zhang G Med Sci Monit; 2019 Jul; 25():5418-5425. PubMed ID: 31326971 [TBL] [Abstract][Full Text] [Related]
14. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells. Kharbanda A; Rajabi H; Jin C; Alam M; Wong KK; Kufe D Oncotarget; 2014 Oct; 5(19):8893-905. PubMed ID: 25245423 [TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M; Zhou LY; Xu N; An Q Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884 [TBL] [Abstract][Full Text] [Related]
16. ILT4 facilitates angiogenesis in non-small cell lung cancer. Wang S; Wang J; Gong W; Zhang F; Chen X; Xu H; Han Y; Fu X; Wang L; Li J; Gao A; Sun Y Cancer Sci; 2024 May; 115(5):1459-1475. PubMed ID: 38433526 [TBL] [Abstract][Full Text] [Related]
17. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer. Ming J; Liu N; Gu Y; Qiu X; Wang EH Pathology; 2009 Feb; 41(2):118-26. PubMed ID: 19152186 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway. Han J; Hu J; Sun F; Bian H; Tang B; Fang X Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways. Cao F; Wang S; Wang H; Tang W Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]